New Delhi, India – 110 016

Our Blog

4MG; 8MG Tablets

5MG; 10MG Tablets

25mg & 12.5mg Tablets

2MG; 5MG Tablets

100mg Injection

1MG Tablets

Gefitinib brought a new lease of life to the treatment of Non-Small Cell Lung Cancer (NSCLC), the first targeted therapy

VEENAT is the product that has redefined the oncology landscape and the market dynamics in favour of the patients in

Sorafenib was the first systemic therapy to be approved for the treatment of Liver cancer (Hepatocellular Carcinoma – HCC), but

NATCO living up to its purpose of “Making speciality medicines accessible to all” has launched generic brands of HEPCINAT (Sofosbuvir),